Vensica Medical Completes $500,000 Finance Round
MISGAV, Israel, July 19, 2016 -- (Healthcare Sales & Marketing Network) -- Vensica Medical, a portfolio company of Trendlines Medical, announced the completion of a financing round of US$500,000 from a private foreign investor. Vensica is developing a ne... Devices, Drug Delivery, Urology, Venture CapitalVensica Medical, overactive bladder, Botox
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Botox | Marketing | Middle East Health | Overactive Bladder | Overactive Bladder Syndrome | Pharmaceuticals | Urology & Nephrology